Quotient Therapeutics

Quotient Therapeutics develops breakthrough medicines informed by natural somatic genetic diversity present in patients. Through our integrated somatic genomics and computational technologies, we gain unbiased, unprecedented resolution into disease-causal drug targets that we leverage to design and develop first-in-class therapies. With this, we are forging a new status quo for biopharma research and development through a broad pipeline of internal and partnered programs. We were founded by Flagship Pioneering in 2022.

Content by Quotient Therapeutics

A graphic of a DNA sequence, showing the different nucleotides represented by A, G, C, and T

Somatic Genomics Reveals Hidden Drivers of Disease

By The Scientist and Quotient Therapeutics | | 5 min read

Page 1 of 1 - 1 Total Items

August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Discover how tissue-resident memory T cells develop within the respiratory tract and how these findings are advancing respiratory virus immunity, vaccine research, and high-throughput immune profiling.

Overcoming Immunotherapy Resistance in Liver Cancer

Explore emerging mechanisms of immune checkpoint inhibitor resistance in hepatocellular carcinoma (HCC) and how combination immunotherapy strategies may improve antitumor immune responses and patient-specific treatment approaches.

Optimizing NGS Library Preparation for Reliable Sequencing Data

Learn practical strategies for optimizing sample preparation, fragmentation, library construction, and quality control to generate high-quality next-generation sequencing (NGS) data across a range of sample types.

Using TCR Repertoire Sequencing to Advance Immunology Research

Learn how bulk T-cell receptor (TCR) repertoire sequencing can reveal clonotype diversity, support immune monitoring, and generate biological insights for translational immunology and biomarker discovery.

Products

Product News

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological’s trial program enables qualified customers to evaluate SuperNuclease Pro in their specific bioprocessing applications, facilitating faster technology assessment and informed decision-making during process development

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

This release expands on Sino Biological's comprehensive Tau protein product portfolio, designed to accelerate neurodegenerative disease research.

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Resipher measures cellular respiration (OCR) continuously in standard 96-well plates inside your incubator, for days to weeks. No media swaps, dyes, or transfers. A live-cell functional readout for drug safety, metabolism, and mitochondrial health.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

The Stirling Ultracold VAULT100™ PRO redefines ultra-low temperature storage with reliable -100°C performance, faster recovery, lower operating costs and sustainable operation. Learn how you can protect critical samples without compromise.